About Zhinuvis
Zhinuvis is a company based in Beijing (China) founded in 2015 by Ling Shaoping. Zhinuvis has raised $8.53 million across 2 funding rounds from investors including Legend Holdings, Huagai Capital and Wutong Tree Insurance Brokers. Zhinuvis operates in a competitive market with competitors including Helix, Benchling, Viz.ai, PathAI and Deepcell, among others.
- Headquarter Beijing, China
- Founders Ling Shaoping
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.53 M (USD)
in 2 rounds
-
Latest Funding Round
$8.53 M (USD), Series B
Nov 22, 2019
-
Investors
Legend Holdings
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Zhinuvis
Zhinuvis has successfully raised a total of $8.53M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $8.53 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Zhinuvis
Zhinuvis has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Legend Holdings, Huagai Capital and Wutong Tree Insurance Brokers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Venture Capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Zhinuvis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zhinuvis
Investment portfolio details for Zhinuvis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zhinuvis
Detailed financials for Zhinuvis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zhinuvis Comparisons
Peer comparison for Zhinuvis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zhinuvis
Zhinuvis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Viz.ai, PathAI and Deepcell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
Detailed competitors of Zhinuvis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zhinuvis
Complete news archive for Zhinuvis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zhinuvis
Zhinuvis was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Zhinuvis is headquartered in Beijing, China.
Ling Shaoping is the current CEO of Zhinuvis. They have also founded this company.
Zhinuvis is a funded company, having raised a total of $8.53M across 2 funding rounds to date.
Zhinuvis was founded in 2015 in Beijing, China, within the healthcare technology sector focused on oncology. AI-based tools are offered for tumor gene and pathology analysis, including the iGeenome Cloud for genetic detection and research, and the iPhenomeCloud for pathology analysis and management. These solutions are targeted at third-party IVD testing institutions, hospital pathology departments, and cancer clinical and drug research organizations, facilitating genomic and pathological data analysis.
Zhinuvis's top competitors include Helix, Benchling and BioAge Labs.
Zhinuvis has 5 investors. Key investors include Legend Holdings, Huagai Capital, Wutong Tree Insurance Brokers, Legend Capital, and Zhen Cheng Capital.